Drug shows potential for weight loss in patients with obesity and diabetes
A new study confirms that treatment with bimagrumab, an antibody that blocks type II activin receptors and stimulates the growth of skeletal muscle, is safe and effective for the treatment of excess adiposity and metabolic disorders in adult patients with obesity and type diabetes 2. The research “These exciting results suggest that there…